Swiss HCVree Trial
NCT02785666
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
HIV
Interventions
DRUG:
grazoprevir/elbasvir, ribavirin
BEHAVIORAL:
Behavioural Intervention
Sponsor
University of Zurich